Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -12,830 | N/A | N/A |
| Depreciation Amortization | 660 | N/A | N/A |
| Other Working Capital | -9,840 | N/A | N/A |
| Other Operating Activity | -2,450 | 0 | 0 |
| Operating Cash Flow | $-24,460 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -530 | N/A | N/A |
| Investing Cash Flow | $-530 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 63,680 | 0 | 0 |
| Financing Cash Flow | $63,680 | $N/A | $N/A |
| Exchange Rate Effect | 2,170 | N/A | N/A |
| Beginning Cash Position | 25,820 | N/A | N/A |
| End Cash Position | 66,680 | N/A | N/A |
| Net Cash Flow | $40,850 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -24,460 | N/A | N/A |
| Free Cash Flow | -24,460 | 0 | 0 |